Next Quarterly Earnings
Wednesday, November 11, 2026
Expected
Ypsomed Holding AG, headquartered in Switzerland (CH), is a leading developer and manufacturer of innovative injection and infusion systems for self-medication. The company specializes in solutions for diabetes management, featuring advanced pen systems and insulin pumps. Ypsomed provides pharmaceutical companies with technologies for safe drug delivery, enhancing the quality of life for patients globally.
Ypsomed Holding last reported quarterly earnings on 5/20/2026 (Q2 2026). Earnings per share (EPS) came in at 6.11 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.